Revenue

The firm reported a Q4 loss but a record $111M backlog fuels its ambitious plan for $150M revenue and a pivot to high-growth quantum and defense markets.

Parse Biosciences, QIAGEN's strategic acquisition, just partnered with Australia's Garvan Institute. It's more than science—it's a calculated play to win.

Once a nanotech firm, then a supplement seller, Bioforce Nanosciences is now an oil explorer. Its new 20,000-acre Nevada lease is a high-stakes gamble to reverse a history of financial peril.

Plumas Bancorp's record earnings are fueled by a major acquisition, but a spike in nonperforming assets reveals the inherent risks of rapid expansion.

SBC Medical is stepping onto the investor stage. We break down their strategy to dominate the booming wellness market, from US expansion to AI-driven healthcare.

Cypriot banktech Xryma Plc is listing on Euronext Paris without raising a cent. We explore the strategy behind this unconventional move and its deep infrastructure play.

After a 90% stock crash since its IPO, activist firm Randian Capital is demanding a strategic review, questioning leadership and industry headwinds.

Serial investor Gary Vaynerchuk takes an equity stake in agency Paul Street, signaling a seismic shift in how premium brands approach partnerships.

Facing a cash crunch and delisting threat, ENvue Medical stacks its board with clinical, AI, and finance heavyweights. Is it a lifeline or a last-ditch effort?

A multi-billion dollar acquisition reunites a CEO with his roots. This is no nostalgia play; it's a calculated move to dominate a changing industry.

Vulcan Materials' upcoming earnings are more than numbers. They're a critical signal for the US economy, revealing the real story behind infrastructure and AI.

Entegris's latest dividend is more than a payout; it's a signal of deep financial health and strategic positioning in the critical semiconductor industry.

A new survey shows a fractured industrial landscape. While some sectors thrive, many face a quiet crisis of tariffs and costs, forcing a turn to data and discipline.

Conagra Brands slashed its dividend by 50%, calling it a 'reset.' We dissect if this is a prudent move to fund growth or a red flag for investors.

BNY's stellar Q2 earnings are more than just numbers. They reveal a strategic pivot to a platform model, AI, and digital assets, setting a new bar.

Rubico Inc. is selling its luxury megayacht to double down on oil tankers. A look at whether this strategic pivot can overcome a history of investor doubt.

Gausium is now the world's #1 cleaning robot supplier. This isn't just about automation; it's a strategic blueprint for scalable, intelligent operations.

Amid market volatility, Hunting PLC's H1 results reveal a successful pivot to high-growth subsea and tech, but can this momentum offset legacy segment lags?

While competitors face a slowdown, the Cartier owner posted a stunning 20% Q1 sales jump. A deep dive into the data reveals a masterclass in strategy.

Decathlon partners with Vusion to equip 700 stores with smart labels, automating pricing to free up staff and eliminate checkout errors for a better experience.